<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Selective <z:chebi fb="19" ids="28790">serotonin</z:chebi> reuptake inhibitors (SSRIs) are the treatment of choice for clinical <z:hpo ids='HP_0000716'>depression</z:hpo> and a range of <z:hpo ids='HP_0000739'>anxiety</z:hpo>-related disorders </plain></SENT>
<SENT sid="1" pm="."><plain>They are well tolerated over extended periods with more than 50 million people worldwide benefiting from their use </plain></SENT>
<SENT sid="2" pm="."><plain>Here we show that 3 structurally distinct SSRIs--<z:chebi fb="0" ids="5118">fluoxetine</z:chebi>, <z:chebi fb="0" ids="7936">paroxetine</z:chebi>, and <z:chebi fb="0" ids="3723">citalopram</z:chebi>--act directly on Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) cells to trigger rapid and extensive programmed cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>SSRIs unexpectedly stimulated calcium flux, tyrosine phosphorylation, and down-regulation of the c-myc and nm23 genes in Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells remaining faithful to the biopsy phenotype </plain></SENT>
<SENT sid="4" pm="."><plain>Resultant SSRI-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> was preceded by caspase activation, poly(<z:chebi fb="13" ids="16761">ADP</z:chebi>-<z:chebi fb="1" ids="33942">ribose</z:chebi>) polymerase-1 (PARP-1) cleavage, DNA fragmentation, a loss of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> membrane potential, and the externalization of phosphatidylserine, and reversed by the overexpression of bcl-2 </plain></SENT>
<SENT sid="5" pm="."><plain><z:mpath ids='MPATH_458'>Normal</z:mpath> peripheral blood mononuclear cells and tonsil B cells, whether resting or stimulated into cycle, were largely resistant to SSRI-induced <z:hpo ids='HP_0011420'>death</z:hpo> as were 5 non-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> lymphoid cell lines tested </plain></SENT>
<SENT sid="6" pm="."><plain>We discuss these findings within the context of whether the SSRI class of antidepressants could find future application as potential therapeutics for the highly aggressive and-because of its association with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>-increasingly more common Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
</text></document>